Evaluation of in vitro genotoxic activity of bleomycin and mitomycin C in human lymphocytes using the alkaline comet assay

Arhiv za Higijenu Rada i Toksikologiju

Volumn 55, Issue 4, 2004, Pages 249-259

  Milić, Mirta ^a   Kopjar, Nevenka ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Antineoplastic drugs; Chemotherapy; DNA damage; DNA repair

Indexed keywords

BLEOMYCIN; MITOMYCIN C;

ADULT; ALKALINE COMET ASSAY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CASE REPORT; CELL PROLIFERATION; COMET ASSAY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CROSS LINKING; DNA DAMAGE; DNA REPAIR; DRUG DNA INTERACTION; DRUG POTENTIATION; DRUG SCREENING; GENOTOXICITY; HUMAN; IN VITRO STUDY; MALE; PERIPHERAL LYMPHOCYTE; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CELLS, CULTURED; COMET ASSAY; DNA DAMAGE; HUMANS; LYMPHOCYTES; MALE; MITOMYCIN; MUTAGENICITY TESTS;

EID: 8744272161     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Colombo P, Gunnarsson K, Iatropoulos M, Brughera M. Toxicological testing of cytotoxic drugs (Rewiev). Int J Oncol 2001;19:1021-8.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some antiviral and antineoplastic drugs and other pharmaceutical agents, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 76. Lyon: International Agency for Research and Cancer; 2000.
3. Kelsey KT, Caggana M, Mauch PM, CN Coleman, Clark JR, Liber HL. Mutagenesis after cancer therapy. Environ Health Persp 1993;101 Suppl 3:177-84.
4. Vig BK, Lewis R. Genetic toxicology of bleomycin. Mutat Res 1978;55:121-45.
5. Povirk LF, Austin MJF. Genotoxicity of bleomycin. Mutat Res 1991;257:127-43.
6. Gonzalez D, Salzaar Saez R, Moreno Rodilla E, Lafford Yges E, Lorente Toledano F. Hypersensitivity reactions to chemotherapy drugs. Alergol Immunol Clin 2000;15: 161-81.
7. Peisach J. Dioxygen activation of iron bleomycin and the cleavage of DMA. Int Congr Ser 2002;1233:511-7.
8. Sugiyama M, Kumagai T. Review: Molecular and Structural Biology of Bleomycin and Its Resistance Determinants. J Biosci Bioeng 2002;93:105-16.
9. Vernole P, Tedeschi B, Caporossi D, Maccarrone M, Melino G, Annicchiarico-Petruzzelli M. Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. Mutagenesis 1998;13:209-15.
10. Xiao Y, Natarajan AT. Analysis of bleomycin-induced chromosomal aberrations in Chinese hamster primary embryonic cells by FISH using arm specific painting probes. Mutagenesis 1999;14:357-64.
11. Lee R, Kim YJ, Lee YJ, Chung HW. The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology 2003;195: 87-95.
12. Puerto S, Surrallés J, Ramírez MJ, Carbonell E, Creus A, Marcos R. Analysis of bleomycin- and cytosine arabinoside-induced chromosome aberrations involving chromosomes 1 and 4 by painting FISH. Mutat Res 1999;439:3-11.
13. Chen J, Stubbe J. Bleomycins: new methods will allow reinvestigation of old issues. Curr Op Chem Biol 2004; 8:175-81.
14. Abraham AT, Lin JJ, Newton DL, Rybak S, Hecht SM. RNA cleavage and inhibition of protein Synthesis by bleomycin. Chem Biol 2003;10:45-52.
15. Papuoli E, Lafon C, Valette A, Zdzienicka MZ, Defais M, Larminat F. Involvement of apoptosis in mitomycin C hypersensitivity of Chinese hamster cell mutants. Biochem Pharmacol 2000;59:1101-7.
16. Carrano AV, Thompson LH, Stretka DG, Minkler JL, Mazrimas JA, Fong S. DNA crosslinking, sister chromatid exchange and specific locus mutations. Mutat Res 1979;63:175-88.
17. Bianchi SM, Larramendy ML, Bianchi NO. Mitomycin C-induced damage and repair in human and pig lymphocytes. Mutat Res 1986;160:27-32.
18. Ceccherini I, Sbrana I, Loprieno N. Kinetics of chromosomal abberations and first mitosis division in human lymphocytes exposed to mitomycin C. Mutat Res 1988;208:183-8.
19. Yamagata Z, Iijima S, Takeshita T, Ariizumi C, Higurashi M. Mitomycin-C-induced sister chromatid exchanges and cell-cycle kinetics in lymphocytes from patients with Klinefelter syndrome. Mutat Res 1989;212:263-8.
20. 0 exposure to mitomycin in vivo vs. in vitro. Mutat Res 1997;49:189-238.
21. Tomasz M, Palom Y. The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity. Pharmacol Th 1997;76:73-87.
22. Giri SD, Chatterjee A. Modulation of mitomycin C-induced sister chromatid exchanges and cell cycle delay by buthionine sulfoximine and reduced glutathione in mouse bone marrow cells in vivo. Mutat Res 1998;413:227-34.
23. Tomasz M. Mitomycin C: small, fast and deadly (but very selective). Chem Biol 1995;2:575-9.
24. Gentile JM, Rahimi S, Zwiesler J, Gentile GJ, Ferguson LR. Effects of selected antimutagens on the genotoxicity of antitumor agents. Mutat Res 1998;402:289-98.
25. Fairbairn DW, Olive PL, O'Neill KL. The comet assay: a comprehensive review. Mutat Res 1995;33:37-59.
26. Olive PL. The comet assay in clinical practice. Acta Oncol 1999;38:839-44.
27. Piperakis SM, Visvardis EE, Tassiou AM. Comet assay for nuclear DNA damage. Methods Enzym 1999;300: 184-94.
28. Singh NP. Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis. Mutat Res 2000;455:111-27.
29. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Rojas E, Ryu JC, Sasaki YF. Single cell gel/Comet assay: guidelines for in uitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-21.
30. Singh NP, McCoy MT, Tice RR, Schneider LL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175: 184-91.
31. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG, Tice R, Waters MD, Aitio A. ICPS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 2000;463:111-72.
32. Šalagovič J, Maes A, Van Gorp U, Verschaeve L, Kalina I. The cell cycle positions Influence DMA migration as measured with the alkaline comet assay in stimulated human lymphocytes. Folia Biol (Praha) 1997;43:79-82.
33. Villani P, Altavista PL, Castaldi L, Leter G, Cordelli E. Analysis of DNA oxidative damage related to cell proliferation. Mutat Res 2000;464:229-37.
34. Miyamae Y, Zaizen K, Ohara K, Mine Y, Sasaki YF. Detection of DNA lesions induced by chemical mutagens by the single cell gel electrophoresis (comet) assay. 1. Relationship between the onset of DNA damage and the characteristics of mutagens. Mutat Res 1998;415:229-35.
35. Frenzilli G, Bosco E, Barale R. Validation of single cell gel assay in human leukocytes with 18 reference compounds. Mutat Res 2000;468:93-108.
36. Fortini P, Raspaglio G, Falchi M, Dogliotti E. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis 1996;11:169-75.
37. Olive PL. DHA damage and repair in individual cells: aplications of the cornet assay in radiobiology. Int J Radiat Biol 1999;75:395-405.
38. Jaloszynski P, Kujawski M, Czub-Świerczek M, Marakowska J, Szyfter K. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 1997;385:223-33.
39. 0 human lymphocytes treated with restriction enzyme Msp1 or bleomycin as shown by the comet assay. Environ Mol Mutagen 1998;32:336-43.
40. Pfeiffer P, Goedecke W, Obe G. Mechanisms of DNA double strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 2000;15:289-302.
41. Utsumi H, Elkind MM. Bleomycin-induced potentially lethal damage and its repair. Radiât Res 1989;119: 534-41.
42. Carloni M, Meschini R, Ovidi L, Palitti F. PHA-induced cell proliferation rescues human peripheral lymphocytes from X-ray induced apoptosis. Mutagenesis 2001;16: 115-20.
43. Mayer C, Popanda O, Zelezny O, von Brevern MC, Bach A, Bartsch H, Schmelzer P. DNA repair capacity after γ-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes. DNA Repair 2002;1:237-50.
44. Harrison L, Malyarchuk S. Can DNA repair cause enhanced cell killing following treatment with ionizing radiation? Pathophysiology 2002;8:149-59.
45. Miyamae Y, Iwasaki K, Kinae N, Tsuda S, Murakami M, Tanaka M, Sasaki JF. Detection of DNA lesions induced by chemical mutagens using the single-cell gel electrophoresis (Comet) assay. 2. Relationship between DHA migration and alkaline condition. Mutat Res 1997;393:107-13.
46. McKenna DJ, Gallus M, McKeown SR, Downes CS, McKelvey-Martin VJ. Modification of the alkaline comet assay to allow simultaneous evaluation of mitomycin C-induced DNA cross-link damage and repair of specific DNA sequences in RT4 cells. DNA Repair 2003;2:879-90.
47. Schlade Bartusiak K, Stembalska-Kozlowska A, Bernady M, Kudyba M, Sasiadek M. Analysis of adaptive response to bleomycin and mytomycin C. Mutat Res 2002;513:75-81.
48. Hartmann A, Speit G. Genotoxic effects of chemicals in the single cell gel (SCG) test with human blood cells in relation to the sister-chromatid exchanges (SCE). Mutat Res 1995;346:49-56.
49. Blasiak J, Gloc E, Warszawski M. A comparison of the in vitro genotoxicity of anticancer drugs idarubicin and mitoxantrone. Acta Biochem Pol 2002;491:145-55.
50. Carbonell E, Demopoulos NA, Stefanou G, Psaraki K, Parry EM, Marcos R. Cytogenetic analysis un peripheral lymphocytes of cancer patients treated with cytostatic drugs: results from an EC Collaborative Study. Anti Cancer Drugs 1996;7:514-9.